Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Melissa Wandoloski
Targeting Polo-Like Kinase 1, a Regulator of P53, in the Treatment of Adrenocortical Carcinoma
Clinical and Translational Medicine
Medicine
Molecular Medicine
Related publications
A Novel Treatment Strategy Targeting Polo-Like Kinase 1 in Hematological Malignancies
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Regulating a Key Mitotic Regulator, Polo-Like Kinase 1 (PLK1)
Cytoskeleton
Cell Biology
Structural Biology
Structural and Functional Analyses of Minimal Phosphopeptides Targeting the Polo-Box Domain of Polo-Like Kinase 1
Nature Structural and Molecular Biology
Structural Biology
Molecular Biology
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Frontiers in Oncology
Cancer Research
Oncology
Polo-Like Kinase-1 as a Novel Target in Neoplastic Mast Cells: Demonstration of Growth-Inhibitory Effects of Small Interfering RNA and the Polo-Like Kinase-1 Targeting Drug BI 2536
Haematologica
Hematology
Myosin Phosphatase-Targeting Subunit 1 Regulates Mitosis by Antagonizing Polo-Like Kinase 1
Developmental Cell
Biochemistry
Developmental Biology
Genetics
Cell Biology
Molecular Biology
PLK1 (Polo-Like Kinase 1 (Drosophila))
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Role of Polo-Like Kinase in the Degradation of Early Mitotic Inhibitor 1, a Regulator of the Anaphase Promoting Complex/Cyclosome
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma
Lymphoma